|
Search
Search through the thousands of lawsuits, complaints and recalls on our site.
 |
Case ID: 3972 | Drugs / Medical | 11/29/2004
Kahn Gauthier Swick is investigating possible legal actions against Medtronic, Inc., manufacturer of the Medtronic Quick Set Plus Insulin Infusion Set and the Medtronic Minimed Paradigm Soft Site Insulin Infusion Set.
The devices are intended for use by insulin dependent diabetics as an insulin delivery system. The devices are designed to remain in place on the user's body for several days at a time and deliver pre-programmed insulin doses. Severe adverse reactions from use of the infusion sets have been reported as a result of the set's failure to issue programmed insulin doses or to sound a warning alarm to alert users to the device malfunction. Over 200 users of the sets have been hospitalized for treatment of conditions related to the malfunction of the insulin delivery devices. Insulin dependent diabetics who utilized the infusion pump systems and did not receive their programmed insulin doses have reported side effects ranging from nausea, weakness and dizziness to kidney failure, coma and death. At Lawcash.com, it is our goal to keep you informed about important legal cases, class actions and settlements. Our lawyers offer free legal evaluations in tort cases, class actions, personal injury, and other lawsuits because we are dedicated to helping you resolve your legal complaints. Other Drugs / Medical Cases of Interest A class action has been filed against AstraZeneca PLC (NYSE:AZN), a pharmaceutical company and certain of its officers and directors by stockholders who purchased the company's common stock between April 2nd, 2003 and October 11th, 2004. The action claims that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. The stockholders seek to recover compensatory damages for the loss of value of their stock. In the wake of Merck’s worldwide recall of the pain medication Vioxx, a growing number and variety of legal actions have been filed against the embattled pharmaceutical giant. This latest is brought under the Federal Employee Retirement Income Security Act (ERISA). Participants in Merck’s employee stock purchase plans say the company’s attempts to cover up the health risks of Vioxx, followed by the eventual recall of the drug, decimated the value of their company stock purchases. The plaintiffs seek damages for the lost value of their stock. Beverly Enterprises Inc. played hardball in two Arkansas courthouses, withholding and losing patient records and other information. One judge has threatened jail time for the company’s chief executive, and another judge granted a default judgment against the company for operating a "shell game."
Federal antitrust laws allow triple punitive damages to be assessed against businesses that wrongfully use monopoly power in the marketplace. A class action has been filed against pharmaceutical company Abbott Laboratories on behalf of persons who have paid out-of-pocket expenses for Norvir (ritonavir), and who allege that the company used its virtual monopoly over the AIDS drug to raise prices 478%, in violation of state and federal antitrust laws. Bayer AG Accused of Using Anthrax Attacks to Maximize Drug Profits at the Expense of Consumer Safety The terrorist attacks of the past two years have created a time to make big profits as well as a time of uncertainty. A class action has been filed against German drug manufacturer Bayer AG and several New Jersey hospitals on behalf of New Jersey postal workers who allege that they have suffered serious side effects from taking the antibiotic ciprofloxacin (Cipro) in the aftermath of the anthrax attacks in 2001. The action alleges that Bayer failed to warn the postal workers of the potential side effects of Cipro, thereby violating the New Jersey Consumer Fraud Act.
A lawsuit filed in Boone County Circuit Court claims that former oncologist James Hueser and 22 physicians shortchanged patients by administering diluted or tainted chemotherapy drugs and charging full price. The former oncologist recently surrendered his license and paid a $1 million fine stemming from accusations of Medicare fraud. The lawsuit seeks class action status and was filed on behalf of Ron Merchant. Hueser treated Merchant's wife, Artie Jean Merchant, who died in 2003 of non-Hodgkin's lymphoma, said an attorney handling the case. |
|
© 2000 - 2008 Copyright. All rights reserved nola3, llc.
